Cleared Dual Track

K240280 - Nano-Check™ RSV Test (FDA 510(k) Clearance)

Jul 2024
Decision
180d
Days
Class 1
Risk

K240280 is an FDA 510(k) clearance for the Nano-Check™ RSV Test. This device is classified as a Antigen, Cf (including Cf Controls), Respiratory Syncytial Virus (Class I - General Controls, product code GQG).

Submitted by Nano-Ditech Corporation (Cranbury, US). The FDA issued a Cleared decision on July 30, 2024, 180 days after receiving the submission on February 1, 2024.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3480.

Submission Details

510(k) Number K240280 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 01, 2024
Decision Date July 30, 2024
Days to Decision 180 days
Submission Type Dual Track
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code GQG - Antigen, Cf (including Cf Controls), Respiratory Syncytial Virus
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3480